Stellato, Marco https://orcid.org/0000-0002-0993-7540
Procopio, Giuseppe
De Giorgi, Ugo
Maruzzo, Marco
Bimbatti, Davide
Mennitto, Alessia
Sbrana, Andrea
Roviello, Giandomenico
Casadei, Chiara
Sepe, Pierangela
Pignata, Sandro
Santini, Daniele
Article History
Received: 6 May 2021
Accepted: 23 July 2021
First Online: 3 August 2021
Declarations
:
: All participating centers received local ethics approval for data collections. All patients signed informed consent to participate to the study.
: Authors received consent for publication.
: Sandro Pignata received honoraria from MSD AZ ROCHE Pfizer GSK Clovis pharmamar and research funding MSD AZ ROCHE PFIZER. Ugo De Giorgi has served as consultant/advisory board member for Astellas, Bayer, BMS, Ipsen, Janssen, Merck, Pfizer and Sanofi; has received travel support from BMS, Ipsen, Janssen and Pfizer; and has received research funding from AstraZeneca, Roche and Sanofi (Inst). All the other authors have no conflict of interest. Daniele Santini received honoraria from MSD, Pfizer, Astellas, Eisai, Janssen, Merck-Serono, Ipsen, Sanofi, BMS.